TransMedics Group Balance Sheet
NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TransMedics Group financial position
At the end of fiscal 2025, TransMedics Group reported total assets of $1.07 billion, up 32.9% from a year earlier against total liabilities of $595.3 million. Shareholders' equity stood at $473.1 million, or 44.3% of assets. The company held $488.4 million in cash and equivalents against $59.6 million of debt, a net cash position of $428.8 million.
The current ratio (current assets divided by current liabilities) was 7.14, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.13.
Summary generated from market data by MetaCap's automated system. Methodology
TransMedics Group balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-28 | FY 20182018-12-29 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 488.37M | 336.65M | 394.81M | 201.18M | 25.58M | 24.58M | 20.09M | 20.24M |
| Short-Term Investments | — | — | — | — | 66.87M | 101.06M | 60.60M | — |
| Receivables | 84.28M | 97.72M | 63.58M | 27.61M | 5.93M | 6.86M | 6.56M | 3.44M |
| Inventory | 48.88M | 46.55M | 44.23M | 20.61M | 14.86M | 11.93M | 11.22M | 9.28M |
| Total Current Assets | 637.78M | 497.22M | 510.65M | 252.29M | 118.70M | 146.77M | 100.00M | 34.79M |
| Property, Plant & Equipment | 327.66M | 285.97M | 173.94M | 19.22M | 9.84M | 4.75M | 4.79M | 3.47M |
| Goodwill | 11.55M | 11.55M | 11.99M | — | — | — | — | — |
| Intangible Assets | 1.95M | 2.15M | 2.35M | — | — | — | — | — |
| Total Assets | 1.07B | 804.08M | 706.05M | 277.15M | 134.89M | 152.03M | 105.30M | 42.16M |
| Accounts Payable | 10.35M | 10.29M | 12.72M | 3.34M | 6.65M | 1.21M | 7.25M | 4.72M |
| Short-Term Debt | 10.00M | — | — | — | — | — | — | — |
| Total Current Liabilities | 89.31M | 59.91M | 54.93M | 23.66M | 23.24M | 11.88M | 16.11M | 12.55M |
| Long-Term Debt | 49.59M | 59.37M | 59.06M | 58.70M | 35.20M | 34.66M | 34.15M | 33.67M |
| Total Liabilities | 595.27M | 575.47M | 568.85M | 89.77M | 67.04M | 48.13M | 50.65M | 47.88M |
| Shareholders' Equity | 473.10M | 228.60M | 137.20M | 187.38M | 67.85M | 103.89M | 54.65M | -192.24M |
| Retained Earnings | -277.95M | -468.24M | -503.70M | -478.68M | -442.45M | -398.23M | -369.48M | -335.94M |
| Total Debt | 59.59M | 59.37M | 59.06M | 58.70M | 35.20M | 34.66M | 34.15M | 33.67M |
| Net Cash (Debt) | 428.78M | 277.28M | 335.75M | 142.49M | 57.26M | 90.98M | 46.54M | -13.43M |
| Shares Outstanding | 34.27M | 33.62M | 32.67M | 32.14M | 27.79M | 27.18M | 21.18M | 1.40M |
This table shows 8 annual periods of TransMedics Group's balance sheet, from FY 2025 back to FY 2018, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TMDX's reporting calendar. What is a balance sheet?